SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-18-030824
Filing Date
2018-02-02
Accepted
2018-02-02 16:38:57
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d514862dsc14d9.htm SC 14D9 1340246
2 EX-99.(A)(2)(O) d514862dex99a2o.htm EX-99.(A)(2)(O) 6855
3 GRAPHIC g514862g19l83.jpg GRAPHIC 26938
4 GRAPHIC g514862g80o87.jpg GRAPHIC 28374
  Complete submission text file 0001193125-18-030824.txt   1424794
Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Filed by) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Subject) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-88476 | Film No.: 18571294
SIC: 2836 Biological Products, (No Diagnostic Substances)